No difference was observed in RFS and OS rates between high SFRP1 expression and low SFRP1 expression groups in HER2-positive (Figure 8E and Figure S4E) and basal breast cancer patients (Figure 8F and Figure S4F). Here, ERBB2 is linked to breast carcinoma.